BLRX BIOLINE RX LIMITED: institutional ownership and insider trading
14 funds reported holding $1.33M of BIOLINE RX LIMITED in their latest 13F filings; in Q2 2026 funds net bought $235K, with 3 new positions and 3 funds selling out.
Famous investors holding BLRX
- Renaissance Technologies (Renaissance Technologies): $48.1K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $45.9K, 0.0% of the portfolio
Largest institutional holders of BLRX
- Banque Cantonale Vaudoise — $1.00M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $217K
- RENAISSANCE TECHNOLOGIES LLC — $48.1K
- CITADEL ADVISORS LLC — $45.9K
- RHUMBLINE ADVISERS — $7.68K
- WELLS FARGO & COMPANY/MN (WFC, WFCNP, WFC-PA, WFC-PC, WFC-PD, WFC-PL, WFC-PY, WFC-PZ) — $6.24K
- BNP PARIBAS FINANCIAL MARKETS — $1.55K
- Nemes Rush Group LLC — $780
- UBS Group AG (UBS) — $315
- NewEdge Advisors, LLC — $256